Selgantolimod Uses, Dosage, Side Effects and more
Selgantolimod is under investigation in clinical trial NCT03491553 (Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-suppressed Adults With Chronic Hepatitis B).
| Trade Name | Selgantolimod |
| Generic | Selgantolimod |
| Selgantolimod Other Names | Selgantolimod |
| Type | |
| Formula | C14H20FN5O |
| Weight | Average: 293.346 Monoisotopic: 293.165188447 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
